Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
Crossref DOI link: https://doi.org/10.1038/leu.2016.6
Published Online: 2016-02-03
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Z
Cortes, J E
Jorgensen, J L
Wang, W
Yin, C C
You, M J
Jabbour, E
Kantarjian, H M
Medeiros, L J
Hu, S
Text and Data Mining valid from 2016-02-03
Version of Record valid from 2016-02-03
Article History
First Online: 3 February 2016
Competing interests
: The authors declare no conflict of interest.